Related Experiment Video
Updated: Nov 25, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway
Yan Cui1, Lin Ma1,2, Stephan Schacke1
1Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), 07745 Jena, Germany.
Abstract:
The Ras-Erk pathway is frequently overactivated in human tumors. Neurofibromatosis types 1 and 2 (NF1, NF2) are characterized by multiple tumors of Schwann cell origin. The NF1 tumor suppressor neurofibromin is a principal Ras-GAP accelerating Ras inactivation, whereas the NF2 tumor suppressor merlin is a scaffold protein coordinating multiple signaling pathways. We have previously reported that merlin interacts with Ras and p120RasGAP. Here, we show that merlin can also interact with the neurofibromin/Spred1 complex via merlin-binding sites present on both proteins. Further, merlin can directly bind to the Ras-binding domain (RBD) and the kinase domain (KiD) of Raf1. As the third component of the neurofibromin/Spred1 complex, merlin cannot increase the Ras-GAP activity; rather, it blocks Ras binding to Raf1 by functioning as a 'selective Ras barrier'. Merlin-deficient Schwann cells require the Ras-Erk pathway activity for proliferation. Accordingly, suppression of the Ras-Erk pathway likely contributes to merlin's tumor suppressor activity. Taken together, our results, and studies by others, support targeting or co-targeting of this pathway as a therapy for NF2 inactivation-related tumors.
Insights
Merlin acts as a selective Ras barrier, blocking Ras from activating the Ras-Erk pathway in Schwann cells. This mechanism contributes to merlin
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- The Ras-Erk pathway is crucial in human tumor development and is frequently overactivated.
- Neurofibromatosis types 1 and 2 (NF1, NF2) are genetic disorders characterized by Schwann cell tumors.
- NF1 tumor suppressor neurofibromin is a Ras-GTPase activating protein (Ras-GAP), while NF2 tumor suppressor merlin is a scaffold protein.
Purpose of the Study:
- To elucidate the molecular mechanisms by which merlin functions as a tumor suppressor.
- To investigate the interaction of merlin with the Ras-Erk pathway components.
- To explore the therapeutic potential of targeting the Ras-Erk pathway in NF2-related tumors.
Main Methods:
- Co-immunoprecipitation assays to study protein interactions.
- In vitro binding assays to confirm direct protein-protein interactions.
- Cell proliferation assays on merlin-deficient Schwann cells.
- Ras-Erk pathway activity assessment.
Main Results:
- Merlin interacts with the neurofibromin/Spred1 complex and directly binds to Raf1's Ras-binding domain and kinase domain.
- Merlin functions as a selective Ras barrier, preventing Ras from binding to Raf1.
- Merlin deficiency leads to increased Ras-Erk pathway activity and Schwann cell proliferation.
- Suppression of the Ras-Erk pathway inhibits proliferation in merlin-deficient Schwann cells.
Conclusions:
- Merlin's tumor suppressor activity in NF2 is mediated by its role in selectively blocking Ras-Raf1 interaction, thereby inhibiting the Ras-Erk pathway.
- Targeting the Ras-Erk pathway is a promising therapeutic strategy for tumors associated with NF2 inactivation.
Related Concept Videos
MAPK Signaling Cascades
The Ras Gene
Ras is a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

